Home » Newsletters » BioWorld

BioWorld

March 7, 2000

View Archived Issues

Appointments And Advancements

Other News To Note

Kinetek Acquires Tyrogene, Completes $13.8M Financing

Myriad Proposes Public Offering Expected To Raise About $327M

Human Genome Sciences Seeks Another $300M In Notes Offering

FDA Issues Warning Letter To Penn Gene Therapy Head

Elan To Acquire Liposome Co. For Stock Worth About $575M

Genzyme Biosurgery Formed From Three-Company Merger

Cyclic Tetrapyrrole Agents Offer Promising Leads For Drugs Against Prion Disease